These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Understanding and managing atherosclerotic renovascular disease: still a work in progress. Chade AR F1000Res; 2018; 7():. PubMed ID: 30631430 [TBL] [Abstract][Full Text] [Related]
44. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. Chade AR; Krier JD; Rodriguez-Porcel M; Breen JF; McKusick MA; Lerman A; Lerman LO Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1079-86. PubMed ID: 14722019 [TBL] [Abstract][Full Text] [Related]
45. Treatment of atherosclerotic renal artery stenosis: time for a new approach. de Leeuw PW; Postma CT; Kroon AA JAMA; 2013 Feb; 309(7):663-4. PubMed ID: 23423409 [No Abstract] [Full Text] [Related]
46. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553 [TBL] [Abstract][Full Text] [Related]
47. Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature. Manolis AS; Manolis AA; Melita H Curr Hypertens Rev; 2017; 13(2):93-103. PubMed ID: 28782466 [TBL] [Abstract][Full Text] [Related]
48. Renal revascularization for hypertension with azotemia. N Engl J Med; 1985 Apr; 312(17):1124-5. PubMed ID: 3157058 [No Abstract] [Full Text] [Related]
49. Update on the management of atherosclerotic renal artery disease. Fenstad ER; Kane GC Minerva Cardioangiol; 2009 Feb; 57(1):95-101. PubMed ID: 19202521 [TBL] [Abstract][Full Text] [Related]
50. Evidence-based medicine in renal artery stenting. Rabbia C; Pini R J Cardiovasc Surg (Torino); 2010 Oct; 51(5):755-63. PubMed ID: 20924335 [TBL] [Abstract][Full Text] [Related]
51. Effect of renal revascularization on the development of renal dysfunction in atherosclerotic ischemic nephropathy. Hagemann R; Silva Vdos S; Franco RJ; Barretti P; Martin LC J Bras Nefrol; 2014; 36(4):535-41. PubMed ID: 25517284 [TBL] [Abstract][Full Text] [Related]
53. With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease. Nyvad J; Lerman A; Lerman LO Hypertension; 2022 Apr; 79(4):717-725. PubMed ID: 35135307 [TBL] [Abstract][Full Text] [Related]
54. High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Ritchie J; Green D; Chrysochou C; Chalmers N; Foley RN; Kalra PA Am J Kidney Dis; 2014 Feb; 63(2):186-97. PubMed ID: 24074824 [TBL] [Abstract][Full Text] [Related]
55. Atherosclerotic renovascular disease in chronic heart failure: should we intervene? de Silva R; Nikitin NP; Bhandari S; Nicholson A; Clark AL; Cleland JG Eur Heart J; 2005 Aug; 26(16):1596-605. PubMed ID: 15919719 [TBL] [Abstract][Full Text] [Related]
56. Renovascular hypertension: diagnostic and therapeutic challenges. Bosmans JL; De Broe ME JBR-BTR; 2004; 87(1):32-5. PubMed ID: 15055332 [TBL] [Abstract][Full Text] [Related]
57. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Levin A; Linas S; Luft FC; Chapman AB; Textor S; Am J Nephrol; 2007; 27(2):212-20. PubMed ID: 17377375 [TBL] [Abstract][Full Text] [Related]